Results 21 to 30 of about 3,981,458 (213)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia [PDF]

Frontiers in Oncology, 2021
This real-world, observational study aimed to assess and compare the clinical efficacy and safety of eltrombopag with recombinant human thrombopoietin (rhTPO) in the treatment of chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma.
Qiuhua Zhu, Shimei Yang, Wenbin Zeng, Mingjie Li, Zebing Guan, Lanlan Zhou, Hong Wang, Yanan Liu, Yanmin Gao, Shiqiu Qiu, Chaolun Chen, Huan Li, Shanshan Zheng, Yuemei Yuan, Hanling Zhang, Xueyi Pan   +15 more
doaj   +2 more sources

Disparities in the consensus for treatment of chemotherapy-induced thrombocytopenia. [PDF]

Ecancermedicalscience, 2023
Chemotherapy-induced thrombocytopenia (CIT) is an arduous complication of chemotherapy to be dealt with, and there are many unmet needs in this field to be addressed on the global front. We have conducted this study to contribute to the understanding of existing knowledge gaps of CIT management and highlight the direction to focus future investigations.
Hambardzumyan L, Grigoryan H, Badikyan M, Khachatryan H, Sargsyan N, Sulikhanyan A, Tamamyan G, Stebbing J.   +7 more
europepmc   +3 more sources

Effects of quercetin and extracts from Phyllanthus emblica, Morus alba, and Ginkgo biloba on platelet recovery in a rat model of chemotherapy-induced thrombocytopenia [PDF]

Heliyon
Background: Chemotherapy-induced thrombocytopenia (CIT) is a major reason for chemotherapy delays, dose reduction, or even treatment discontinuation, which may impact oncologic outcomes.
Kriangkrai Chawansuntati, Sayamon Hongjaisee, Kittichai Sirita, Kornkamon Kingkaew, Kritsadee Rattanathammethee, Benjawan Kumrapich, Sakaewan Ounjaijean, Aphisek Kongkaew, Nongkran Lumjuan   +8 more
doaj   +2 more sources

‘Pseudo Wine Glass’ Radiological Appearance of Intracranial Haemorrhage as a Result of Chemotherapy-Induced Thrombocytopenia and Red Cell Sedimentation

Case Reports in Oncology, 2010
The radiological features of intracranial haemorrhage are well described in the literature, but atypical appearances can sometimes develop. We report a case of chemotherapy-induced thrombocytopenia resulting in fatal intracranial haemorrhage in a man ...
O. Oladipo, R. Kennedy, A. Shiels, S. McAleer   +3 more
doaj   +2 more sources

Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I Study. [PDF]

Cancers (Basel)
Background/Objectives: Intensive chemotherapy is the cornerstone of lymphoma treatment but often leads to severe chemotherapy-induced thrombocytopenia (sCIT), resulting in treatment delays, reduced dose intensity, and the need for transfusions.
Joffe E, Epstein-Peterson Z, Falchi L, Noy A, Zelenetz AD, Owens C, Gilbert L, Salles G, Soff GA.   +8 more
europepmc   +2 more sources

Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor [PDF]

, 2011
Purpose: Chemotherapy-induced apoptosis of immature hematopoietic cells is a major cause of anemia and thrombocytopenia in cancer patients. Although hematopoietic growth factors such as erythropoietin and colony-stimulating factors cannot prevent the ...
Zapparelli, G, Dattilo, R, Martineti, D, Di Virgilio, A, Biffoni, M, Bartucci, M, TODARO, Matilde, De Maria, R, Zeuner, A.   +8 more
core   +4 more sources

Efficacy of Carica Papaya Leaf Extract in Reducing Treatment-Delay Secondary to Chemotherapy induced Thrombocytopenia [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Chemotherapy Induced Thrombocytopenia (CIT) is a common problem in clinical oncology. It leads to delay in administration of chemotherapy resulting in inferior outcomes.
Priyanka Sreelatha, Wesley Mannirathil Jose   +1 more
doaj   +1 more source

Efficacy and Safety of Different Treatments in Chemotherapy-Induced Thrombocytopenia: A Systematic Review and Network Meta-Analysis [PDF]

Frontiers in Pharmacology
Libai Chen, Jingyu Gao, Xuedong Wu
exaly   +2 more sources

P142 | ROMIPLOSTIM AS A TREATMENT FOR CHEMOTHERAPY INDUCED THROMBOCYTOPENIA: THREE CASE REPORTS AND A LITERATURE REVIEW

Haematologica
Chemotherapy-induced thrombocytopenia (CIT) is a common hematologic complication of cancer treatment, characterized by decreased platelet counts due to the cytotoxic effects of chemotherapy on megakaryocytes.
G. Fornari, D. Cilloni, A. Ferrero, G. Valabrega   +3 more
doaj   +1 more source

Thrombosis Research / Challenging anticoagulation cases: cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - a case-based review of clinical management

, 2021
Patients with cancer undergoing chemotherapy are at risk of thrombocytopenia. The co-incidence of cancer-associated venous thromboembolism (VTE) and thrombocytopenia is a frequent complication in patients with cancer.
Makatsariya, Alexander, Moik, Florian, Ay, Cihan   +2 more
core   +1 more source